参考文献/References:
[1]郭伟.腹主动脉瘤诊断与治疗指南.中国实用外科杂,2008,28(11):916-918.
[2]Erbel R, Aboyans V, Boileau C,et al; ESC Committee for Practice Guidelines. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases:document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).Eur Heart J,2014,35(41):2873-2926.
[3]Ay D, Erdolu B, Yumun G,et al.The effect of anatomical factors on mortality rates after endovascular aneurysm repair.Cardiovasc J Afr,2016,27(1):12-15.
[4]程灿,胡何节,王晓天,等.高危腹主动脉瘤患者腔内修复术并发症分析.中华普通外科杂志,2015,30(3):231-234.
[5]刘澄,乔彤.肾下型腹主动脉瘤腔内术后内漏病因分析.国际外科杂志,2018,45(3):109-202.
[6]谷涌泉,郭连瑞,齐立行,等.复杂腹主动脉瘤腔内修复65例经验.中国微创外科杂志,2016,16(3):224-232.
[7]于晓强,岳嘉宁,董智慧,等.复合支架方案在复杂肾下腹主动脉瘤腔内治疗中的应用及疗效观察.中华医学杂志,2016,96(18):1430-1434.
[8]王永刚,史振宇,符伟国,等.Endurant支架治疗短瘤颈腹主动脉瘤临床疗效分析.中华外科杂志,2017,55(6):451-454.
[9]Haulon S,Amiot S,Magnan PE,et al.An analysis of the French multicentre experience of fenestrated aortic endografts:mediumterm outcomes.Ann Surg,2010,251:357-362.
[10]冯家烜,陆清声,景在平,等.腹主动脉瘤腔内隔绝术中Ⅰ型内漏的纤维蛋白胶栓塞治疗.中华外科杂志,2011,49(10):883-887.
[11]褚永新,陆清声,张雷,等.纤维蛋白粘合剂配合无造影剂腔内隔绝术.临床外科杂志,2018,26(2):117-120.
[12]杜昕,郭伟,刘小平,等.腹主动脉瘤腔内修复术中瘤腔内压力监测的意义.中华普通外科杂志,2008,25(3):353-355.